Skip to main content
Article thumbnail
Location of Repository

Mesenchymal Differentiation and Organ Distribution of Established Human Stromal Cell Lines in NOD/SCID Mice

By Karin Thalmeier, Petra Meissner, Sabine Moosmann, Sabine Sagebiel, Irmgard Wiest and Ralf Huss


Two human stromal cell lines were established previously from bone marrow-derived primary long-term cultures by immortalization using the SV40 large T antigen and cellular cloning. After irradiation, the fibroblast-like cell lines L87/4 and L88/5 support hematopoietic differentiation of allogeneic cord blood cells in vitro. The stromal cells do not express CD34 and CD50, but some adhesion molecules and integrins, such as CD44, CD54 and CD58. Their expression profiles on RNA and protein levels are suggestive of their osteogenic potency. The quality and quantity of osteocalcin and osteopontin protein expression depended on the culture conditions. Expression of the osteogenic markers increased over time in culture, especially in cells growing in clusters. The stromal cells also expressed collagens I and V, but did not show any expression of collagens II and III. The potentially osteoblastic stromal cells were transplanted into NOD/SCID recipient mice by intravenous injection and were found in various mesenchymal organs up to 10 weeks after transplantation. Osteocalcin-positive human stromal cells could be detected in the bone marrow, thymus, liver, brain and gut of the recipient animals. In summary, there is evidence that human bone-marrow-derived stromal cells have to be considered mesenchymal progenitors, persistently expressing osteogenic markers in vitro and in vivo. Copyright (C) 2001 S, Karger AG, Basel.

Topics: Medizin, ddc:610
Publisher: Ludwig-Maximilians-Universität München
Year: 2001
DOI identifier: 10.1159/000046559
OAI identifier:
Provided by: Open Access LMU

Suggested articles


  1. (1998). CD34-negative stem cells as the earliest precursors of hematopoietic progeny. Exp Hematol
  2. Constitutive and modulated cytokine expression in two permanent human bone marrow stromal cell line. Exp Hematol
  3. Deeg HJ: Differentiation of canine marrow cells with hematopoietic characteristics from an adherent stromal cell precursor.
  4. (1994). Dörmer P: Establishment of two permanent bone marrow stromal cell lines with long-term post-irradiation feeder capacity.
  5. et al: Muscle regeneration by bone marrow-derived myogenic progenitors.
  6. (1984). Fialkow PF: Evidence for a stem cell common to hematopoiesis and its in vitro microenvironment: Studies of patients with clonal hematopoietic neoplasia. Leuk Res
  7. (2000). Heinrich PC: Quiescence of CD34-negative hematopoietic stem cells is mediated by downregulation of cyclin B and no STAT activation. Cytokine
  8. (1999). Hematopoietic reconstitution of syngeneic mice with a peripheral blood-derived, monoclonal CD34–, Sca-1+, Thy-1low, c-kit+ stem cell line.
  9. (1997). HJ: CD34-negative hematopoietic stem cells isolated from human peripheral blood cells as ultimate precursors of hematopoietic progenitors. Infusionsther Transfusionsmed
  10. (1995). HJ: Contact and growth factor involved in proliferation and differentiation in a canine marrow-derived stromal cell line.
  11. HJ: Stroma derived hematopoietic progenitors: Cell cycle dependent proliferation and differentiation; in Gluckman E, Coulombel E (eds): Ontogeny of Hematopoiesis. Aplastic Anemia. Colloque Inserm.
  12. (1998). Human bone marrow CD34-negative cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp Hematol
  13. (1998). JE: A newly discovered class of human hematopoietic cells with SCID-repopulating activity.
  14. (1996). Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell.
  15. Marrow stromal cells as stem cells for nonhematopoietic tissue. Science 1997;276:
  16. (2000). Mesenchymal stem cells: Biology and potential clinical uses. Exp Hematol
  17. (1999). MK: Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.
  18. (1997). Muschler GF: Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation.
  19. (1998). Nuclear matrix proteins and osteoblast gene expression.
  20. PJ: The STRO-1+ fraction of adult bone marrow contains osteogenic precursors. Blood 1994;84:
  21. (1996). RC: Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
  22. Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63.
  23. (1994). Terstappen LWMM: Formation of hematopoietic microenvironment and hematopoietic stem cells from single human bone marrow stem cells (correction).
  24. (1992). Terstappen LWMM: Formation of hematopoietic microenvironment and hematopoietic stem cells from single human bone marrow stem cells.
  25. Thalmeier K: Evidence of peripheral bloodderived, plastic adherent CD34–/low hematopoietic stem cell clones with mesenchymal stem cell characteristics. Stem Cells 2000;18:
  26. The peripheral blood fibrocyte is a potent antigenpresenting cell capable of priming naive T cells in situ.
  27. (1991). Torok-Storb B: CD34 expression by stromal precursors in normal human adult bone marrow.
  28. (1993). U: In vitro expression of osteoblastic markers in cells isolated from normal fetal and postnatal human bone and from bone of patients with osteogenesis imperfecta.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.